CHF and Arrhythmias Archives - Page 156 of 159 - MPR

CHF and Arrhythmias

Too High, Too Low Serum Potassium Linked to Mortality

Patients hospitalized after an acute myocardial infarction (AMI) with post-admission serum potassium levels between 3.5 and 4.5mEq/L (milliEquivalents per liter) have a lower risk of death than those with higher or lower levels, according to a study published in the January 11 issue of the Journal of the American Medical Association.

BRILINTA (ticagrelor) 90mg tablets by AstraZeneca

Oral Antiplatelet Agent Brilinta Approved

AstraZeneca announced that Brilinta (ticagrelor), an oral antiplatelet agent, has been approved to reduce the rate of thrombotic cardiovascular events in patients with ACS (unstable angina [UA] non-ST-elevation myocardial infarction [NSTEMI], or ST-elevation myocardial infarction [STEMI]).